Innate resistance and therapeutic-driven development of resistance to anticancer drugs is a common complication of cancer therapy. Understanding mechanisms of drug resistance can lead to development of alternative therapies. One strategy is to subject drug-sensitive and drug-resistant variants to single-cell RNA-seq (scRNA-seq) and to subject the scRNA-seq data to network analysis to identify pathways associated with drug resistance. This protocol describes a computational analysis pipeline to study drug resistance by subjecting scRNA-seq expression data to Passing Attributes between Networks for Data Assimilation (PANDA), an integrative network analysis tool that incorporates protein-protein interactions (PPI) and transcription factor (TF)-binding motifs.
Keywords: Connectivity map analysis; Data integration; Drug resistance network; Gene set enrichment analysis; Passing Attributes between Networks for Data Assimilation; Protein–protein interactions; Single-cell RNA-sequencing; Transcription factor-binding motifs.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.